Literature DB >> 3410490

BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.

L Varga1, E Thiry, G Füst.   

Abstract

The binding of 125I-BSA-anti-BSA immune complexes (IC) formed in the presence of complement (nascent IC) and those that reacted with complement after their formation (preformed IC) to human erythrocytes was studied. The effect of antigen-antibody ratios and serum dilutions on IC binding to red blood cells (RBC) were also investigated. A dramatic difference was found between the behaviour of the two types of complexes: while preformed IC bound effectively to human RBC after their interaction with complement, no efficient RBC-binding was observed with nascent BSA-anti-BSA complexes formed in the presence of complement. Changing the antigen-antibody ratio or dilution of serum did not affect markedly the extent of difference between the binding of preformed and nascent IC. Our findings do not support the essential role of red blood cells in the elimination of each type of IC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410490      PMCID: PMC1385046     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells.

Authors:  I I Onyewotu; E J Holborow; G D Johnson
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

3.  The red-cell immune system.

Authors:  I Siegel; T L Liu; N Gleicher
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

5.  Competition for immune complexes by red cells in human blood.

Authors:  M E Medof; J J Oger
Journal:  J Clin Lab Immunol       Date:  1982-01

6.  Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia.

Authors:  L Varga; Z Miszlay; E Czink; K Pálóczi; G Szegedi; G Füst; S R Hollán
Journal:  Diagn Clin Immunol       Date:  1987

7.  Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.

Authors:  P M Henson; Z G Oades
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

8.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Enhancement of platelet response to immune complexes and IgG aggregates by lipid A-rich bacterial lipopolysaccharides.

Authors:  M H Ginsberg; P M Henson
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  3 in total

1.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  Immune adherence of nascent hepatitis B surface antigen-antibody complexes in vivo in humans.

Authors:  N Madi; J P Paccaud; G Steiger; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

Review 3.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.